Clinical Trial Update: Erythropoietin Therapy in Patients With Chronic Renal Failure: A Study of Time Dependent Activity [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating time-dependent activity of erythropoietin therapy in patients with chronic kidney disease-related anemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Chronic Kidney Disease

Drugs mentioned

• Erythropoietin (erythropoietin)

Snippet

Sponsor: Sunnybrook Health Sciences Centre | Conditions: Hemodialysis, Chronic Renal Failure | Phase 2 | Status: COMPLETED